In recent years Alzheimer’s disease (AD) has emerged as a research priority mainly due to an impressive increase in the average life expectancy in humans, which is associated with debilitating neurodegenerative disorders. The cardinal feature of the disease is accumulation of the amyloid-? peptide, which is derived from the sequential proteolytic cleavage of the amyloid precursor protein (APP). SorLA (sorting protein-related receptor with A-type repeats) is a member of the VPS10p-domain receptor gene family and identified as a significant sorting receptor that controls the processing and trafficking of APP. This review systematically discusses information on sorLA associations with AD including the mechanisms that regulate sorLA activity. W...
OBJECTIVE: Sorting-related receptor with type A repeats (SORLA) is a neuronal sorting receptor that ...
sorLA is a sorting receptor for amyloid precursor protein (APP) genetically linked to Alzheimer's di...
Prior to intervention trials in individuals genetically at-risk for late-onset Alzheimer\u27s diseas...
Alzheimer's disease (AD) represents one of the most dramatic threats to healthy aging and devising e...
SORLA is a sorting receptor known to control the intracellular trafficking of the amyloid precursor ...
The proteolytic breakdown of the amyloid precursor protein (APP) to neurotoxic amyloid-beta peptides...
SORLA is a neuronal sorting receptor implicated both in sporadic and familial forms of AD. SORLA red...
sorLA is a recently identified neuronal receptor for amyloid precursor protein (APP) that is known t...
Introduction: Sorting-related receptor with A-type repeats (SORLA) is an intracellular sorting recep...
BACKGROUND: Proteolytic breakdown of the amyloid precursor protein (APP) by secretases is a complex ...
The recycling of the amyloid precursor protein (APP) from the cell surface via the endocytic pathway...
Sorting protein-related receptor with A-type repeats (SORLA) is a major risk factor in cellular proc...
sorLA (sorting protein-related receptor) is a type-1 membrane protein of unknown function that is ex...
SORLA/SORL1 is a unique neuronal sorting receptor for the amyloid precursor protein that has been ca...
SORLA (sorting protein-related receptor with A type repeats) is a type-I membrane receptor belonging...
OBJECTIVE: Sorting-related receptor with type A repeats (SORLA) is a neuronal sorting receptor that ...
sorLA is a sorting receptor for amyloid precursor protein (APP) genetically linked to Alzheimer's di...
Prior to intervention trials in individuals genetically at-risk for late-onset Alzheimer\u27s diseas...
Alzheimer's disease (AD) represents one of the most dramatic threats to healthy aging and devising e...
SORLA is a sorting receptor known to control the intracellular trafficking of the amyloid precursor ...
The proteolytic breakdown of the amyloid precursor protein (APP) to neurotoxic amyloid-beta peptides...
SORLA is a neuronal sorting receptor implicated both in sporadic and familial forms of AD. SORLA red...
sorLA is a recently identified neuronal receptor for amyloid precursor protein (APP) that is known t...
Introduction: Sorting-related receptor with A-type repeats (SORLA) is an intracellular sorting recep...
BACKGROUND: Proteolytic breakdown of the amyloid precursor protein (APP) by secretases is a complex ...
The recycling of the amyloid precursor protein (APP) from the cell surface via the endocytic pathway...
Sorting protein-related receptor with A-type repeats (SORLA) is a major risk factor in cellular proc...
sorLA (sorting protein-related receptor) is a type-1 membrane protein of unknown function that is ex...
SORLA/SORL1 is a unique neuronal sorting receptor for the amyloid precursor protein that has been ca...
SORLA (sorting protein-related receptor with A type repeats) is a type-I membrane receptor belonging...
OBJECTIVE: Sorting-related receptor with type A repeats (SORLA) is a neuronal sorting receptor that ...
sorLA is a sorting receptor for amyloid precursor protein (APP) genetically linked to Alzheimer's di...
Prior to intervention trials in individuals genetically at-risk for late-onset Alzheimer\u27s diseas...